ReviewFrontiers in immunology2020

CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer.

Mohammadreza Azangou-Khyavy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.